Urologists critical of HIFU on Twitter

Article

Urologists on Twitter criticized high-intensity focused ultrasound and in some instances even mocked the treatment.

Urologists on Twitter criticized high-intensity focused ultrasound (HIFU) and in some instances even mocked the treatment.

Their comments came in response to a recent "Speak Out" article in which urologists discussed HIFU, as well as results from a Urology Times poll showing that 54% of respondents feel that HIFU has a future in the U.S. for treating prostate cancer. Declan Murphy, MB BCH, had a strong reaction to the poll results:

US urologists vote for HIFU @UrologyTimes. Have you all gone mad?? pic.twitter.com/VopwOPKyqr

- Declan Murphy (@declangmurphy) February 13, 2014
 

Other users mocked the treatment by joking about comical alternate uses for it:

 

@declangmurphy@daviesbj@UrologyTimes Could use it to warm coffee up I suppose #hifulatte

- Cycling Urologist (@KearsleyJamie) March 1, 2014

@declangmurphy@daviesbj HIFU machine would probably make a nice pot plant holder or prop for UFO movie ( anal probing etc ) #HIFUuses

- Cycling Urologist (@KearsleyJamie) March 1, 2014
 

Not everyone was completely negative about HIFU, however. Urologist Mutahar Ahmed, MD, of the New Jersey Center for Prostate Cancer & Urology, tweeted: 

 

@UrologyTimes#prostatecancer#hifu. HIFU will have limited role in prostate cancer but may play bigger role in kidney cancer

- Mutahar Ahmed (@RoboticsUrology) January 1, 2014

Subscribe to Urology Times to get monthly news from the leading news source for urologists.


 

Recent Videos
Tony Abraham, DO, MPA, a nuclear radiologist
Kelly L. Stratton, MD, FACS, answers a question during a Zoom video interview
Kyrollis Attalla, MD, an expert on prostate cancer
Kyrollis Attalla, MD, an expert on prostate cancer
Tony Abraham, DO, MPA, a nuclear radiologist
Tony Abraham, DO, MPA, a nuclear radiologist
Adity Dutta, MSN, AGACNP-BC, gives an answer during a video interview
Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.